{"id":"metformin-intermittent-insulin-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Gastrointestinal disturbance (metformin)"},{"rate":null,"effect":"Weight gain (insulin)"},{"rate":null,"effect":"Injection site reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metformin is a biguanide that decreases gluconeogenesis and enhances peripheral glucose uptake, reducing fasting and postprandial glucose levels. Intermittent insulin therapy involves periodic insulin administration to supplement endogenous insulin secretion and achieve target blood glucose levels. The combination leverages metformin's insulin-sensitizing effects with insulin's direct glucose-lowering action.","oneSentence":"Metformin reduces hepatic glucose production and improves insulin sensitivity, while intermittent insulin therapy provides periodic exogenous insulin to maintain glycemic control.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:20:57.742Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus (Phase 3 investigational combination regimen)"}]},"trialDetails":[{"nctId":"NCT06882291","phase":"NA","title":"Intermittent Fasting Diet Versus Resistive Exercise Program on Insulin Resistance in Obese Women With P.C.O.S","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-03-20","conditions":"Polycystic Ovary Syndrome","enrollment":72},{"nctId":"NCT04146155","phase":"PHASE4","title":"Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-05-01","conditions":"Type 2 Diabetes, Peripheral Vascular Disorder Due to Diabetes Mellitus","enrollment":200},{"nctId":"NCT02192424","phase":"PHASE3","title":"Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2014-07","conditions":"Type 2 Diabetes","enrollment":109},{"nctId":"NCT01755468","phase":"PHASE3","title":"Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2013-04","conditions":"Type 2 Diabetes","enrollment":24},{"nctId":"NCT01799057","phase":"PHASE4","title":"The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication","status":"TERMINATED","sponsor":"Baker Heart and Diabetes Institute","startDate":"2013-07","conditions":"Peripheral Arterial Disease, Intermittent Claudication","enrollment":2}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["metformin,","basal insulin glargine and pre-meal insulin lispro"],"phase":"phase_3","status":"active","brandName":"Metformin + Intermittent Insulin Therapy","genericName":"Metformin + Intermittent Insulin Therapy","companyName":"Mount Sinai Hospital, Canada","companyId":"mount-sinai-hospital-canada","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metformin reduces hepatic glucose production and improves insulin sensitivity, while intermittent insulin therapy provides periodic exogenous insulin to maintain glycemic control. Used for Type 2 diabetes mellitus (Phase 3 investigational combination regimen).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}